Colossal Biosciences aims to resurrect the woolly mammoth using gene-editing techniques, claiming it could help combat climate change and restore Arctic ecosystems. With significant advancements in stem cell technology and genetic engineering, the company has garnered public and investor interest, leading to a valuation of $10 billion. However, some experts argue these efforts may distract from important conservation needs, warning that reviving extinct species for spectacle may not effectively address the urgent ecological challenges faced by endangered species and global ecosystems.
The company aims to use gene-editing to revive woolly mammoths, believing it could combat climate change by restoring Arctic ecosystems and protecting endangered species.
Colossal's ambitious plans for de-extinction raise concerns that the project may prioritize spectacle over genuine conservation, risking misallocation of resources for wildlife preservation.
Collection
[
|
...
]